NEA Management Company, LLC Q3 2018 Filing
Filed November 13, 2018
Portfolio Value
$2.3T
Holdings
44
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TESARO INC | 10,420,555 | $406.5B | 17.54% | |
| 2 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 15,832,611 | $214.7B | 9.26% | |
| 3 | SENS1GBPSENSEONICS HOLDINGS INC | 30,888,266 | $147.3B | 6.36% | |
| 4 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $143.3B | 6.18% | |
| 5 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $130.9B | 5.65% | |
| 6 | ALLKGUSDALLAKOS INC | 2,268,188 | $102.0B | 4.40% | |
| 7 | —RA PHARMACEUTICALS INC | 5,493,636 | $99.4B | 4.29% | |
| 8 | CRSPCRISPR THERAPEUTICS AG | 2,090,678 | $92.7B | 4.00% | |
| 9 | —OBSEVA SA | 4,586,563 | $82.7B | 3.57% | |
| 10 | —MERSANA THERAPEUTICS INC | 8,144,267 | $81.4B | 3.51% | |
| 11 | —EPIZYME INC | 6,460,851 | $68.5B | 2.96% | |
| 12 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $68.2B | 2.94% | |
| 13 | ARDXARDELYX INC | 15,335,047 | $66.7B | 2.88% | |
| 14 | —AVEO PHARMACEUTICALS INC | 18,698,038 | $61.9B | 2.67% | |
| 15 | —SYNLOGIC INC | 4,229,410 | $60.1B | 2.59% | |
| 16 | BEBLOOM ENERGY CORP | 1,333,333 | $45.4B | 1.96% | |
| 17 | —DERMIRA INC | 3,506,649 | $38.2B | 1.65% | |
| 18 | SURFUSDSURFACE ONCOLOGY INC | 3,315,149 | $36.3B | 1.57% | |
| 19 | AUPHAURINIA PHARMACEUTICALS INC | 4,808,483 | $31.9B | 1.38% | |
| 20 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $27.3B | 1.18% | |
| 21 | —REGULUS THERAPEUTICS INC | 10,989,010 | $26.0B | 1.12% | |
| 22 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $25.4B | 1.10% | |
| 23 | MEIPUSDMEI PHARMA INC | 5,720,572 | $24.7B | 1.06% | |
| 24 | —CLEMENTIA PHARMACEUTICALS INC | 2,141,697 | $23.9B | 1.03% | |
| 25 | —AFFIMED NV | 5,138,888 | $22.4B | 0.96% | |
| 26 | —ACHAOGEN INC | 5,215,128 | $20.8B | 0.90% | |
| 27 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $20.1B | 0.87% | |
| 28 | —GENOCEA BIOSCIENCES INC | 25,000,000 | $19.5B | 0.84% | |
| 29 | VRNAVERONA PHARMA PLC | 1,219,674 | $15.3B | 0.66% | |
| 30 | —NIGHTSTAR THERAPEUTICS PLC | 714,285 | $14.6B | 0.63% | |
| 31 | —ARQULE INC | 2,520,316 | $14.3B | 0.62% | |
| 32 | —DASAN ZHONE SOLUTIONS INC | 956,255 | $13.6B | 0.59% | |
| 33 | —PROTEOSTASIS THERAPEUTICS INC | 5,556,778 | $13.4B | 0.58% | |
| 34 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $10.4B | 0.45% | |
| 35 | CTIC1USDCTI BIOPHARMA CORP | 3,750,000 | $8.1B | 0.35% | |
| 36 | —TREVENA INC | 3,811,691 | $8.1B | 0.35% | |
| 37 | TREURTRILLIUM THERAPEUTICS INC | 1,250,000 | $7.3B | 0.31% | |
| 38 | —TRACON PHARMACEUTICALS INC | 3,467,181 | $7.1B | 0.31% | |
| 39 | ERYP1EURERYTECH PHARMA SA | 625,000 | $5.4B | 0.23% | |
| 40 | —ENDOLOGIX INC | 2,490,204 | $4.8B | 0.21% | |
| 41 | —ARSANIS INC | 2,000,000 | $3.2B | 0.14% | |
| 42 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $2.6B | 0.11% | |
| 43 | —AKARI THERAPEUTICS PLC | 452,167 | $1.2B | 0.05% | |
| 44 | —AYTU BIOSCIENCE INC | 2,246 | $6.0M | 0.00% |